Vibrocil Actilong nasal spray

Vibrocil Actilong is a well-known nasal decongestant containing xylometazoline hydrochloride, designed to provide long-lasting relief from nasal congestion. The brand Vibrocil has a long history in the pharmaceutical industry and was originally developed by Zyma SA, a Swiss healthcare company that later became part of Ciba-Geigy and subsequently Novartis.

Following a major joint venture and subsequent demerger involving GSK (GlaxoSmithKline) and Novartis, the consumer healthcare portfolio, which includes Vibrocil, was transitioned to Haleon. Haleon is now a dominant global player in consumer health, headquartered in the United Kingdom. While the brand has Swiss roots, manufacturing occurs across various global pharmaceutical facilities to meet international demand, particularly within the European market.